Olga Karapanou

6PUBLICATIONS
4CO-AUTHORS
Planning and decision makingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 26, 2026
Promise and pitfalls of AI chatbots in complex decision-making for thyroid nodules and papillary thyroid cancer.

Grigoris Effraimidis, Athanasios Kasotas, Sofia Varsami

|Feb 28, 2025
Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for change.

Grigoris Effraimidis, Eleni Sazakli, Olga Karapanou

|Feb 19, 2025
Local treatments and TKI efficacy in radioiodine refractory differentiated thyroid carcinoma patients: a single center experience.

Katerina Saltiki, Olga Karapanou, Kanella Kantreva

|Mar 10, 2022
Advanced RAI-refractory thyroid cancer: an update on treatment perspectives.

Olga Karapanou, George Simeakis, Barbara Vlassopoulou

|Mar 08, 2021
Histology is more ιmportant than persistent anti-Tg antibodies for progression of differentiated thyroid cancer.

Olga Karapanou, Katerina Saltiki, George Simeakis

Pageof 1